Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yin, An an ^a   Zhang, Lu hua ^a   Cheng, Jin xiang ^a   Dong, Yu ^b   Liu, Bo lin ^a   Han, Ning ^a   Zhang, Xiang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

AMINOTRANSFERASE BLOOD LEVEL; AMNESIA; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONSTIPATION; DEPRESSION; ELDERLY CARE; FATIGUE; GLIOBLASTOMA; HUMAN; INFECTION; LEUKOENCEPHALOPATHY; META ANALYSIS; NAUSEA AND VOMITING; QUALITY OF LIFE; RASH; RISK REDUCTION; SIDE EFFECT; STOMATITIS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; GLIOBLASTOMA; HUMANS;

EID: 84884549320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074242     Document Type: Article

References (63)

1. Wen PY, Kesari S, (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
2. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE, (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64: 628-634.
3. Kita D, Ciernik IF, Vaccarella S, Franceschi S, Kleihues P, et al. (2009) Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology 33: 17-22.
4. Siu LL, (2007) Clinical trials in the elderly-a concept comes of age. N Engl J Med 356: 1575-1576.
5. Laperriere N, Weller M, Stupp R, Perry JR, Brandes AA, et al. (2012) Optimal management of elderly patients with glioblastoma. Cancer Treat Rev. DOI: 10.1016/j.ctrv.2012.05.008.
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
7. Macdonald DR, Cascino TL, Schold SJ, Cairncross JG, (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280.
8. Higgins JP, Green S Cochrane Handbook for Systematic Reviews of Interventions. Available at http://handbook.cochrane.org/.Accessed 2013 Jan 05.
9. Wells G, Shea B, O′Connell D, Peterson J, Welch V,et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed Jan 5, 2013.
10. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR, (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16.
11. Petretta M, Pirozzi F, Sasso L, Paglia A, Bonaduce D, (2011) Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Am J Cardiol 108: 1171-1176.
12. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
13. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
14. Perry JR, O′Callaghan CJ, Ding K, Roa W, Mason WP, et al. (2012) A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma. J Clin oncol 30 (suppl): S2104.
15. Ackerl MS, Flechl B, Dieckmann K, Preusser M, Widhalm G, et al. (2012) Outcome evaluation in glioblastoma patients older than 65 years: A retrospective single center study. Neuro Oncol 14(suppl. 3): i46-i47.
16. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, et al. (2003) A prospective study on glioblastoma in the elderly. Cancer 97: 657-662.
17. Dirier A, Abacioglu U, Okkan S, Pak Y, Guney YY, et al. (2010) Radiotherapy with or without temozolomide in elderly glioblastoma patients: Performance or age as a surrogate? Neuro Oncol 12(suppl. 4): v42.
18. Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, et al. (2011) Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103: 611-618.
19. Kimple RJ, Grabowski S, Papez M, Collichio F, Ewend MG, et al. (2010) Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme? Am J Clin Oncol 33: 265-270.
20. Kushnir I, Tzuk-Shina T, (2011) Efficacy of treatment for glioblastoma multiforme in elderly patients (65+): a retrospective analysis. Isr Med Assoc J 13: 290-294.
21. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, et al. (2006) Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol 76: 159-163.
22. Niyazi M, Schwarz SB, Suchorska B, Belka C, (2012) Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Strahlenther Onkol 188: 154-159.
23. Piccirilli M, Bistazzoni S, Gagliardi FM, Landi A, Santoro A, et al. (2006) Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years. Tumori 92: 98-103.
24. Sijben AE, McIntyre JB, Roldan GB, Easaw JC, Yan E, et al. (2008) Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 89: 97-103.
25. Stummer W, Nestler U, Stockhammer F, Krex D, Kern BC, et al. (2011) Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 103: 361-370.
26. Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, et al. (2012) Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg. DOI: 10.3171/2012.10.JNS112268.
27. Cao JQ, Fisher BJ, Bauman GS, Megyesi JF, Watling CJ, et al. (2012) Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. J Neurooncol 107: 395-405.
28. Muni R, Minniti G, Lanzetta G, Caporello P, Frati A, et al. (2010) Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. Tumori 96: 60-64.
29. Abhinav K, Aquilina K, Gbejuade H, La M, Hopkins K, et al. (2013) A pilot study of glioblastoma multiforme in elderly patients: Treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival. Clin Neurol Neurosurg. DOI: 10.1016/j.clineuro.2012.12.023.
30. Barker CA, Chang M, Chou JF, Zhang Z, Beal K, et al. (2012) Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol 109: 391-397.
31. Caroli M, Vetrano IG, Lucarella F, Di Cristofori A, Pluder M, et al. (2011) Treatment of cerebral glioblastoma in elderly patients. Eur J Cancer 47(suppl. 1): S581.
32. Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, et al. (2012) Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer 131: 1342-1350.
33. Sharp HJ, Skinner HD, Chang EL, Settle SH, Sulman EP, et al. (2011) Concurrent temozolomide and radiation in elderly patients with glioblastoma: A retrospective analysis. Int J Radiat Oncol Biol Phys 81(suppl. 1): S278-S279.
34. Smith S, Heron NA, Wheeler HR, Back M, (2011) Management of glioblastoma in NSCCH elderly patients between 2006 and 2010. Asia-Pacific Journal of Clinical Oncology 7(suppl. 4): 76.
35. Fiorentino A, Balducci M, De Bonis P, Chiesa S, De Filippo L, et al. (2013) Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? Am J Clin Oncol.
36. Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, et al. (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83: 93-99.
37. Lee JH, Jung TY, Jung S, Kim IY, Jang WY, et al. (2013) Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme. J Clin Neurosci. DOI: 10.1016/j.jocn.2012.03.044.
38. Reyngold M, Lassman AB, Chan TA, Yamada Y, Gutin PH, et al. (2012) Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status. J Neurooncol 110: 369-374.
39. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, et al. (2008) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88: 97-103.
40. Minniti G, Salvati M, Arcella A, Buttarelli F, D′Elia A, et al. (2011) Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurooncol 102: 311-316.
41. Abdel Karim K, Abdel Wahab MM, Ezz LR, Abdel Raouf S, (2012) Preserved quality of life for older patients with glioblastoma treated with reduced dose of radiotherapy and temozolomide. Neuro Oncol 14(suppl. 3): i22.
42. Laperriere N, Menard C, Millar BA, Sahgal A, Payne D, et al. (2010) Prognostic factors and outcomes for elderly patients withglioblastoma multiforme. Radiotherapy Oncology 96(suppl. 2): S34.
43. Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, et al. (2012) Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients- Early Results of a Phase II Trial. Front Oncol 2: 122.
44. Minniti G, De Sanctis V, Muni R, Rasio D, Lanzetta G, et al. (2009) Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J Neurooncol 91: 95-100.
45. Balducci M, Fiorentino A, De Bonis P, Chiesa S, Manfrida S, et al. (2012) Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies. Med Oncol 29: 3478-3483.
46. Brandes AA, Franceschi E, Tosoni A, Benevento F, Scopece L, et al. (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115: 3512-3518.
47. Weiss SE, Cheung A, Drappatz J, (2010) Hypofractionated radiotherapy with temozolomide for elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 78(suppl. 1): S271.
48. Combs SE, Wagner J, Bischof M, Welzel T, Wagner F, et al. (2008) Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70: 987-992.
49. Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, et al. (2010) Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother Oncol 97: 382-386.
50. Hashem SA, Salem A, Al-Rashdan A, Ezam N, Nour A, et al. (2012) Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme. J Med Imaging Radiat Oncol 56: 204-210.
51. Zachenhofer I, Maier R, Eiter H, Muxel M, Cejna M, et al. (2011) Overall survival and extent of surgery in adult versus elderly glioblastoma patients: A population based retrospective study. Wien Klin Wochenschr 123: 364-368.
52. Fiorentino A, Fusco V (2012) Elderly Patients Affected by Glioblastoma Treated With Radiotherapy: The Role of Serum Hemoglobin Level. Int J Neurosci. DOI: 10.3109/00207454.2012.744309.
53. Fiorica F, Berretta M, Colosimo C, Stefanelli A, Ursino S, et al. (2010) Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch Gerontol Geriatr 51: 31-35.
54. Gerstner ER, Yip S, Wang DL, Louis DN, Iafrate AJ, et al. (2009) Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma. Neurology 73: 1509-1510.
55. Mishima K, Adachi J, Suzuki T, Wakiya K, Yanagisawa T, et al. (2010) Radiotherapy plus concomitant and adjuvant themozolomide for glioblastoma in elderly patients. Neuro Oncol 12(suppl. 3): i46.
56. Saito K, Mukasa A, Narita Y, Tabei Y, Shinoura N, et al. (2011) Efficacy and safety of temozolomide added to radiotherapy for glioblastoma in the elderly. Neuro-Oncology 13(suppl. 3): i44.
57. Pichlmeier U, Bink A, Schackert G, Stummer W, (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10: 1025-1034.
58. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, et al. (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62: 564-576, 564-576.
59. Ven Den Ben M, Stupp R, Mason W, (2005) Impact of extent of resection on overall survivalin newly-diagnosed glioblastoma after chemo-irradiation with temozolomide:further analysis of EORTC study 26981 [abstract]. Eur J Cancer 41: 134.
60. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003.
61. Malmstrom A, Gronberg BH, Marosi C, Stupp R, Frappaz D, et al. (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13: 916-926.
62. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, et al. (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13: 707-715.
63. Cheng JX, Zhang X, Liu BL, (2009) Health-related quality of life in patients with high-grade glioma. Neuro Oncol 11: 41-50.